October 6, 2021
Via: European Pharmaceutical ReviewThe US Food and Drug Administration (FDA) has released new draft guidance surrounding on ‘Microbiological Quality Considerations in Non-Sterile Drug Manufacturing’. The draft will be available for public comment for up to 90 days after 30 September 2021. The guidance […]
July 11, 2024
July 11, 2024
July 19, 2024